More News! 26 Jul 2024
Confo Therapeutics raises $60 million to focus on agonistic GPCR antibodies
Discover the field of agonistic GPCR antibodies after Confo therapeutics successfully raised $60 million in its series B round.
Funding
- Latest Posts
More News! 17 Jul 2024
Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it
Discover yet another exciting deal in biotech with Asceneuron raising $100 million to advance its Alzheimer’s candidate, ASN51.
News and Trends 16 Jul 2024
German biotech raises $150M on its way to tackle cancer therapy resistance
On its way to tackle cancer therapy resistance with its monoclonal antibody visugromab, CataLym completes a $150 million series D round.
Best in Biotech 11 Jul 2024
From data to discovery: Five bioinformatics companies you should know in 2024
Bioinformatics integrates computer technology to analyze biological data to boost R&D. Here are five companies at the top of their game in 2024.
Best in Biotech 9 Jul 2024
The 7 biotech companies in Portugal you should know about in 2024
We take a look at seven biotech companies in Portugal, which is home to a rich biotech ecosystem that is rapidly growing.
Expert Advice 5 Jul 2024
The ABC of biotech startup funding
Funding a biotech startup can be challenging. Delve into our guide to navigate this complicated investment landscape.
ADVERTISEMENT
ADVERTISEMENT
In Depth 4 Jul 2024
The biggest private biotech investments in June 2024
The companies Formation Bio, Isotopen Technologien München, and Marea Therapeutics bagged the biggest private biotech investments in June 2024.
In Depth 28 Jun 2024
Going nuclear: radiopharmaceuticals funding sees surge in 2024
Emerging as a new class of drugs, radiopharmaceuticals are all the rage in cancer treatment research as biotechs nab major funding deals.
Best in Biotech 25 Jun 2024
Spotlight on Georgia’s biotech industry: Seven companies to know about in 2024
Delve into the biotech landscape of the state of Georgia and discover seven companies leading the charge in the industry.
Best in Biotech 20 Jun 2024
CRISPR technology’s next wave: Eight companies to watch in 2024
Driven by CASGEVY’s success, the CRISPR field is experiencing substantial growth with a new wave of companies.
In Depth 17 Jun 2024
Moving with the times: biopharma royalty deals on the rise
A spate of royalty deals are changing the way certain biotechs press ahead. This trend seems to be an alternative to traditional biopharma fundraising.
Best in Biotech 13 Jun 2024
Eight companies tackling cancer with allogeneic cell therapy in 2024
Unlike autologous cell therapy, where the patient’s own cells are used, allogeneic cell therapy companies leverage donor cells, which can come from various sources such as bone marrow or umbilical cord blood. In allogeneic cell therapy, healthy donor cells are harvested, processed, and then infused into the patient. These donor cells can differentiate into various […]
ADVERTISEMENT